Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DGXNYSE:DVANYSE:LHNASDAQ:PRSC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$177.73+0.4%$175.77$136.30▼$182.38$19.84B0.49994,306 shs1.21 million shsDVADaVita$141.70+0.4%$139.46$131.76▼$179.60$10.70B1.11802,301 shs1.15 million shsLHLabcorp$260.30+1.3%$248.19$198.96▼$264.03$21.79B0.81636,373 shs1.02 million shsPRSCProvidence Service$3.41-3.1%$144.13$40.40▼$156.30$48.37M0.84128,367 shs2.26 million shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics0.00%-0.88%+2.69%+4.93%+29.85%DVADaVita0.00%+3.69%+4.13%-7.49%+2.26%LHLabcorp0.00%-0.66%+4.70%+11.81%+27.90%PRSCProvidence Service0.00%+5.25%+160.31%+144.44%-87.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDGXQuest Diagnostics4.9431 of 5 stars2.34.04.24.73.42.52.5DVADaVita4.1216 of 5 stars2.01.00.04.51.61.73.8LHLabcorp4.4306 of 5 stars2.42.02.54.23.42.51.3PRSCProvidence ServiceN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGXQuest Diagnostics 2.69Moderate Buy$185.734.50% UpsideDVADaVita 2.00Hold$164.5016.09% UpsideLHLabcorp 2.79Moderate Buy$276.086.07% UpsidePRSCProvidence Service 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PRSC, LH, DGX, and DVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingCautious ➝ Cautious6/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$250.00 ➝ $275.006/11/2025LHLabcorpMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$270.00 ➝ $283.005/19/2025DVADaVitaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$170.00 ➝ $164.005/12/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$274.00 ➝ $290.005/6/2025LHLabcorpPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.005/6/2025DGXQuest DiagnosticsJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$180.00 ➝ $190.004/30/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$240.00 ➝ $250.004/30/2025LHLabcorpRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$253.00 ➝ $267.004/28/2025DGXQuest DiagnosticsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$180.00 ➝ $200.004/23/2025DGXQuest DiagnosticsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$182.00 ➝ $190.00(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGXQuest Diagnostics$9.87B2.01$13.50 per share13.17$61.38 per share2.90DVADaVita$12.82B0.83$19.15 per share7.40$4.83 per share29.34LHLabcorp$13.01B1.67$22.38 per share11.63$96.27 per share2.70PRSCProvidence Service$1.51B0.03$0.10 per share32.54$24.61 per share0.14Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGXQuest Diagnostics$871M$7.9122.4716.942.488.81%15.11%6.65%7/22/2025 (Estimated)DVADaVita$936.34M$10.0914.0411.150.986.63%176.11%4.66%8/5/2025 (Estimated)LHLabcorp$746M$8.6530.0914.841.655.55%15.27%6.97%7/30/2025 (Estimated)PRSCProvidence Service$970K$1.65N/A0.99N/A0.23%17.59%8.74%N/ALatest PRSC, LH, DGX, and DVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2025Q2 2025DGXQuest Diagnostics$2.56N/AN/AN/A$2.73 billionN/A5/12/2025Q1 2025DVADaVita$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billion4/29/2025Q1 2025LHLabcorp$3.73$3.84+$0.11$2.52$3.41 billion$3.35 billion4/22/2025Q1 2025DGXQuest Diagnostics$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDGXQuest Diagnostics$3.201.80%N/A40.46%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLabcorp$2.881.11%N/A33.29%N/APRSCProvidence ServiceN/AN/AN/AN/AN/ALatest PRSC, LH, DGX, and DVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/20254/10/2025LHLabcorpquarterly$0.721.25%5/29/20256/11/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGXQuest Diagnostics0.841.441.31DVADaVita23.181.251.20LHLabcorp0.681.841.60PRSCProvidence Service0.071.221.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGXQuest Diagnostics88.06%DVADaVita90.12%LHLabcorp95.94%PRSCProvidence ServiceN/AInsider OwnershipCompanyInsider OwnershipDGXQuest Diagnostics8.16%DVADaVita2.00%LHLabcorp0.84%PRSCProvidence Service7.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDGXQuest Diagnostics56,000111.64 million102.53 millionOptionableDVADaVita76,00075.50 million73.99 millionOptionableLHLabcorp70,00083.70 million83.00 millionOptionablePRSCProvidence Service3,80014.18 millionN/ANot OptionablePRSC, LH, DGX, and DVA HeadlinesRecent News About These CompaniesPRSC awards honors champions in Permian Basin Road SafetyMarch 5, 2025 | yahoo.comProvidence church holds first Sunday service since Wednesday fireFebruary 3, 2025 | msn.comRhode Island Public Transit Authority to hold public hearings on proposed service changesNovember 26, 2024 | turnto10.comTThe Providence Performing Arts Center Announces New Teen Ambassador ProgramNovember 13, 2024 | broadwayworld.comProvidence Classical School Celebrates Veterans at Annual CeremonyNovember 12, 2024 | wydaily.comWProvidence public school district admits student vaccine records, driver’s licenses were stolen in cyberattackNovember 12, 2024 | bostonglobe.comBThe Consolation of ProvidenceNovember 12, 2024 | christianitytoday.comCProvidence Journal printing plant to close due to supply chain issueNovember 12, 2024 | msn.comProvidence Journal printing facility to close, shifting to alternative facilitiesNovember 12, 2024 | msn.comJudge rules in favor of state and Providence school officials in funding war. What to know.November 10, 2024 | providencejournal.comPProvidence holds ceremony to promote 21 police officers to supervisory ranksNovember 8, 2024 | msn.comProvidence police officers to be promoted to supervisory ranksNovember 8, 2024 | abc6.comAHere’s who won Providence’s first School Board election in 60 yearsNovember 7, 2024 | bostonglobe.comBProvidence's home health care services face changes with new partnershipNovember 4, 2024 | khq.comKProvidence Place mall turned over to veteran RI receivership attorneysNovember 4, 2024 | msn.com‘Do not punish kids’: Providence students demand more school funding amid threatened cuts to sports, transportationNovember 4, 2024 | bostonglobe.comBJudge puts Providence Place mall into receivershipNovember 2, 2024 | msn.comProvidence Place mall is headed into receivership. Here's what that means.November 2, 2024 | providencejournal.comPUPDATED: Receiver Named by Judge Stern for Providence Place Mall CaseNovember 2, 2024 | golocalprov.comGProvidence Place Mall to be Placed Into ReceivershipNovember 1, 2024 | golocalprov.comGNew MarketBeat Followers Over TimeMedia Sentiment Over TimePRSC, LH, DGX, and DVA Company DescriptionsQuest Diagnostics NYSE:DGX$177.73 +0.67 (+0.38%) Closing price 06/27/2025 03:59 PM EasternExtended Trading$175.08 -2.65 (-1.49%) As of 06/27/2025 05:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$141.70 +0.61 (+0.44%) Closing price 06/27/2025 03:59 PM EasternExtended Trading$146.00 +4.30 (+3.03%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Labcorp NYSE:LH$260.30 +3.32 (+1.29%) Closing price 06/27/2025 03:59 PM EasternExtended Trading$220.22 -40.08 (-15.40%) As of 05:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.Providence Service NASDAQ:PRSCThe Providence Service Corporation provides healthcare services in the United States. It operates through Non-Emergency Medical Transportation Services (NET Services) and Matrix Investment segments. The NET Services segment offers non-emergency medical transportation services for Medicaid or Medicare eligible members, whose limited mobility or financial resources hinder their ability to access necessary healthcare and social services. The Matrix Investment segment provides in-home care optimization services, including comprehensive health assessments through a network of community-based clinicians and a fleet of mobile health clinics. The company was founded in 1996 and is headquartered in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
